Gregory B. Collins

614 total citations
23 papers, 463 citations indexed

About

Gregory B. Collins is a scholar working on Epidemiology, General Health Professions and Molecular Biology. According to data from OpenAlex, Gregory B. Collins has authored 23 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in General Health Professions and 4 papers in Molecular Biology. Recurrent topics in Gregory B. Collins's work include Substance Abuse Treatment and Outcomes (6 papers), Smoking Behavior and Cessation (3 papers) and Opioid Use Disorder Treatment (3 papers). Gregory B. Collins is often cited by papers focused on Substance Abuse Treatment and Outcomes (6 papers), Smoking Behavior and Cessation (3 papers) and Opioid Use Disorder Treatment (3 papers). Gregory B. Collins collaborates with scholars based in United States. Gregory B. Collins's co-authors include Jason M. Jerry, Mark McAllister, Sergey Sheleg, Mark P. Jensen, Don W. Shoeman, Paul R. Pentel, Mark LeSage, Dan E. Keyler, K. Bridget Brosnihan and Manjula K. Gupta and has published in prestigious journals such as Anesthesia & Analgesia, Alcoholism Clinical and Experimental Research and Psychiatric Services.

In The Last Decade

Gregory B. Collins

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory B. Collins United States 11 91 86 76 73 70 23 463
John E. Peachey Canada 18 161 1.8× 126 1.5× 22 0.3× 89 1.2× 66 0.9× 36 695
François Paillé France 16 213 2.3× 107 1.2× 25 0.3× 73 1.0× 38 0.5× 65 1.0k
Hugh Claridge United Kingdom 13 82 0.9× 32 0.4× 203 2.7× 82 1.1× 74 1.1× 20 457
Thomas M. Penders United States 12 76 0.8× 50 0.6× 146 1.9× 124 1.7× 85 1.2× 24 569
Christine Goodair United Kingdom 10 79 0.9× 24 0.3× 178 2.3× 62 0.8× 74 1.1× 23 388
Jason M. Jerry United States 10 58 0.6× 48 0.6× 95 1.3× 73 1.0× 43 0.6× 14 455
Gail Somer Canada 12 235 2.6× 107 1.2× 44 0.6× 135 1.8× 95 1.4× 19 658
Trond Oskar Aamo Norway 17 91 1.0× 58 0.7× 88 1.2× 137 1.9× 77 1.1× 35 795
Joan A. Marshman Canada 11 73 0.8× 27 0.3× 24 0.3× 25 0.3× 53 0.8× 26 381
D Ladewig Switzerland 17 158 1.7× 78 0.9× 91 1.2× 281 3.8× 65 0.9× 73 915

Countries citing papers authored by Gregory B. Collins

Since Specialization
Citations

This map shows the geographic impact of Gregory B. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory B. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory B. Collins more than expected).

Fields of papers citing papers by Gregory B. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory B. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory B. Collins. The network helps show where Gregory B. Collins may publish in the future.

Co-authorship network of co-authors of Gregory B. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory B. Collins. A scholar is included among the top collaborators of Gregory B. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory B. Collins. Gregory B. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jerry, Jason M., et al.. (2015). E-cigarettes: Safe to recommend to patients?. Cleveland Clinic Journal of Medicine. 82(8). 521–526. 12 indexed citations
2.
Collins, Gregory B., Jason M. Jerry, & Robert Bales. (2014). Quitting smoking: Still a challenge, but newer tools show promise. Cleveland Clinic Journal of Medicine. 82(1). 39–48. 5 indexed citations
3.
Jerry, Jason M. & Gregory B. Collins. (2013). Medication-assisted treatment of opiate dependence is gaining favor. Cleveland Clinic Journal of Medicine. 80(6). 345–349. 9 indexed citations
4.
Jerry, Jason M., et al.. (2012). Synthetic legal intoxicating drugs: The emerging ‘incense’ and ‘bath salt’ phenomenon. Cleveland Clinic Journal of Medicine. 79(4). 258–264. 78 indexed citations
5.
Collins, Gregory B.. (2011). All tarred with the same brush. ANU Open Research (Australian National University). 7(3). 60–76.
6.
Sheleg, Sergey & Gregory B. Collins. (2011). A Coincidence of Addiction to “Kratom” and Severe Primary Hypothyroidism. Journal of Addiction Medicine. 5(4). 300–301. 66 indexed citations
7.
Tetzlaff, John E., et al.. (2010). A strategy to prevent substance abuse in an academic anesthesiology department. Journal of Clinical Anesthesia. 22(2). 143–150. 25 indexed citations
8.
Collins, Gregory B. & Mark McAllister. (2008). Chloroquine Psychosis Masquerading as PCP: A Case Report. Journal of Psychoactive Drugs. 40(2). 211–214. 14 indexed citations
9.
Collins, Gregory B. & Mark McAllister. (2007). Buprenorphine maintenance: a new treatment for opioid dependence.. Cleveland Clinic Journal of Medicine. 74(7). 514–520. 12 indexed citations
10.
Collins, Gregory B., et al.. (2007). Patient-Provider E-Mail Communication as an Adjunctive Tool in Addiction Medicine. Journal of Addictive Diseases. 26(2). 45–52. 6 indexed citations
11.
Collins, Gregory B., et al.. (2006). Drug adjuncts for treating alcohol dependence.. Cleveland Clinic Journal of Medicine. 73(7). 641–644. 11 indexed citations
12.
McAllister, Mark & Gregory B. Collins. (2006). Anabolic-Androgenic Steroid Abuse by Physicians. Journal of Addictive Diseases. 25(3). 105–110. 8 indexed citations
13.
Collins, Gregory B., et al.. (2005). Chemical Dependency Treatment Outcomes of Residents in Anesthesiology: Results of a Survey. Anesthesia & Analgesia. 101(5). 1457–1462. 52 indexed citations
14.
LeSage, Mark, et al.. (2002). Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacology Biochemistry and Behavior. 72(1-2). 279–289. 74 indexed citations
15.
Collins, Gregory B.. (1994). Why Treatment for Alcohol Dependence is Changing. Alcoholism Treatment Quarterly. 12(2). 23–39. 5 indexed citations
16.
Collins, Gregory B., et al.. (1992). Neuroendocrine, Fluid Balance, and Thirst Responses to Alcohol in Alcoholics. Alcoholism Clinical and Experimental Research. 16(2). 228–233. 47 indexed citations
17.
Collins, Gregory B., et al.. (1987). Dental management of the recovered chemically dependent patient. The Journal of the American Dental Association. 114(5). 601–603. 7 indexed citations
18.
Collins, Gregory B., et al.. (1981). Propoxyphene dependence. Postgraduate Medicine. 70(6). 57–61. 6 indexed citations
19.
Collins, Gregory B.. (1981). Treatment of alcoholism. Postgraduate Medicine. 69(1). 145–149. 2 indexed citations
20.
Collins, Gregory B., et al.. (1980). A hospital day care program for alcoholics. General Hospital Psychiatry. 2(1). 20–22. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026